Canada's construction news
Indiana-based Eli Lilly is making the single biggest U.S. investment in synthetic medicine manufacturing at a new state business park in Lebanon, Ind.
The campus will comprise 600 acres and begin production in 2026, “scaling up” through 2028, according to a company release. The corporation declined further comment. The investment will expand Lilly’s ability to manufacture active pharmaceutical ingredients for Zepbound injection and Mounjaro injection. These drugs are for adults with chronic diseases like obesity and Type 2 diabetes.Not only is this the largest investment in synthetic drug manufacturing but it’s Lilly’s largest investment ever.
Indiana Gov. Eric Holcomb said the state attributes the investment to its “leadership” in developing sites like the LEAP Research and Innovation District.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Britain Poised to Offer Eli Lilly’s Weight-Loss Drug to PatientsEli Lilly & Co.’s Mounjaro is being recommended for weight loss for some UK patients with obesity, in draft guidance that could see the National Health Service offer a rival drug to Novo Nordisk A/S’s hit treatment Wegovy.
Read more »
Eli Lilly’s Obesity Drug Crunch Shows Signs of Easing in JapanEli Lilly & Co.’s hefty investment in expanding production capacity for its popular weight-loss and diabetes drugs is starting to pay off in Japan, allowing the company to lift shipment controls it imposed in the country last year.
Read more »
FDA Staff Proposes Narrow Approval for Lilly’s Alzheimer’s DrugUS drug regulatory staffers are considering a more targeted approval for Eli Lilly & Co.’s experimental Alzheimer’s disease treatment than the company wants, potentially limiting the market for a would-be blockbuster.
Read more »
Lilly Alzheimer’s Drug Seen Effective by FDA Advisory PanelEli Lilly & Co.’s treatment for Alzheimer’s disease works in at least some patients, according to a US advisory panel.
Read more »
FDA panel votes to recommend Eli Lilly's Alzheimer's drugA US Food and Drug Administration (FDA) panel voted unanimously 11-0 to recommend the approval of Eli Lilly's (LLY) Alzheimer's drug, donanemab. Yahoo...
Read more »
Eli Lilly's new Alzheimer's treatment could 'lift' drug marketEli Lilly (LLY) is one step closer to getting its new Alzheimer's treatment approved by the Food and Drug Administration (FDA) after a panel voted to...
Read more »